← Evidence map

ReviewThe oncologist2024

Advances and future directions in ROS1 fusion-positive lung cancer.

Mary C Boulanger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

23 papers cite it

2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 39177972